Skip to main content
OpenTrials
Completed

NCT Number: NCT06151132

Treatment of Atrial Fibrillation in the Community Settings

Description of treatment of cardiovascular diseases in community settings in Russia

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Arrhythmia Cardiovascular Diseases

Sex eligibility

All sexes

Study type

Observational

About this study

The study will describe different treatment modalities used in management of cardiovascular diseases in community hospital in small town of Tarusa in Russia. This part of the study will focus on atrial fibrillation and its treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients undergoing direct current cardioversion for atrial fibrillation or flutter

Exclusion criteria

  • none

Treatment and study plan

Direct current cardioversion

Procedure

Direct current cardioversion to maintain sinus rhythm during rhythm control strategy

Primary outcomes

  1. Restoration of sinus rhythm

    Time frame: 1 day

    Restoration of sinus rhythm during direct current cardioversion

  2. Maintenance in rhythm control strategy

    Time frame: 7 years

    Maintenance in rhythm control strategy during treatment of atrial fibrillation

Other outcomes

  1. Gender

    Time frame: During procedure

    Gender

  2. Age

    Time frame: During procedure

    Age

  3. Body mass index

    Time frame: During procedure

    weight in kilograms divided by the square of height in meters

  4. Heart Failure

    Time frame: Before procedure

    Past history of chronic heart failure

  5. Arterial hypertension

    Time frame: Before procedure

    Past history of arterial hypertension

  6. Coronary heart disease

    Time frame: Before procedure

    Past history of coronary heart disease

  7. Diabetes mellitus

    Time frame: Before procedure

    Past history of diabetes mellitus

  8. Type of arrhythmia

    Time frame: During procedure

    Atrial fibrillation or atrial flutter

  9. Duration of arrhythmia

    Time frame: Before procedure

    Duration of episode of arrhythmia before cardioversion

  10. Settings

    Time frame: During procedure

    Whether procedure performed in inpatient or outpatient settings

  11. TEE

    Time frame: Before procedure

    Whether transesophageal echocardiography was performed before procedure

  12. First procedure

    Time frame: Before procedure

    Whether it is the first cardioversion in the patient

  13. Echo LVEF

    Time frame: During procedure

    Left ventricular ejection fraction measured by echocardiography

  14. Echo LAVI

    Time frame: During procedure

    Left atrium volume index measured by echocardiography

Sponsors and collaborators

Lead sponsor

ITMO University

Other

Registry information

Important dates

Study start
2016
Primary completion
2022
Study completion
2023
First posted
Nov 30, 2023
Registry last updated
Nov 30, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.